Bioxcel Therapeutics shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $23k | 38k | 0.60 |
| 2024-06-30 | $49k | 38k | 1.29 |
| 2024-03-31 | $107k | 38k | 2.81 |
| 2023-12-31 | $112k | 38k | 2.94 |
| 2021-09-30 | $223k | 7.4k | 30.34 |
| 2021-06-30 | $310k | 11k | 29.05 |
| 2021-03-31 | $348k | 8.1k | 43.12 |
| 2020-12-31 | $263k | 5.7k | 46.14 |
| 2020-09-30 | $264k | 6.1k | 43.28 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors